Literature DB >> 22525157

Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.

Lianne Robinson1, Jacky Guy, Leanne McKay, Emma Brockett, Rosemary C Spike, Jim Selfridge, Dina De Sousa, Cara Merusi, Gernot Riedel, Adrian Bird, Stuart R Cobb.   

Abstract

Rett syndrome is a neurological disorder caused by mutation of the X-linked MECP2 gene. Mice lacking functional Mecp2 display a spectrum of Rett syndrome-like signs, including disturbances in motor function and abnormal patterns of breathing, accompanied by structural defects in central motor areas and the brainstem. Although routinely classified as a neurodevelopmental disorder, many aspects of the mouse phenotype can be effectively reversed by activation of a quiescent Mecp2 gene in adults. This suggests that absence of Mecp2 during brain development does not irreversibly compromise brain function. It is conceivable, however, that deep-seated neurological defects persist in mice rescued by late activation of Mecp2. To test this possibility, we have quantitatively analysed structural and functional plasticity of the rescued adult male mouse brain. Activation of Mecp2 in ∼70% of neurons reversed many morphological defects in the motor cortex, including neuronal size and dendritic complexity. Restoration of Mecp2 expression was also accompanied by a significant improvement in respiratory and sensory-motor functions, including breathing pattern, grip strength, balance beam and rotarod performance. Our findings sustain the view that MeCP2 does not play a pivotal role in brain development, but may instead be required to maintain full neurological function once development is complete.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525157      PMCID: PMC3437019          DOI: 10.1093/brain/aws096

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  54 in total

Review 1.  Motor symptoms of the Rett syndrome: abnormal muscle tone, posture, locomotion and stereotyped movement.

Authors:  Y Nomura; M Segawa
Journal:  Brain Dev       Date:  1992-05       Impact factor: 1.961

2.  A role for glia in the progression of Rett's syndrome.

Authors:  Daniel T Lioy; Saurabh K Garg; Caitlin E Monaghan; Jacob Raber; Kevin D Foust; Brian K Kaspar; Petra G Hirrlinger; Frank Kirchhoff; John M Bissonnette; Nurit Ballas; Gail Mandel
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

3.  Rett syndrome: spinal cord neuropathology.

Authors:  A Oldfors; B Hagberg; H Nordgren; P Sourander; I Witt-Engerström
Journal:  Pediatr Neurol       Date:  1988 May-Jun       Impact factor: 3.372

4.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Selective dendritic alterations in the cortex of Rett syndrome.

Authors:  D Armstrong; J K Dunn; B Antalffy; R Trivedi
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

6.  Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder.

Authors:  P O Julu; A M Kerr; F Apartopoulos; S Al-Rawas; I W Engerström; L Engerström; G A Jamal; S Hansen
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

7.  Morphological study of neocortical areas in Rett syndrome.

Authors:  P V Belichenko; B Hagberg; A Dahlström
Journal:  Acta Neuropathol       Date:  1997-01       Impact factor: 17.088

8.  Regression in individuals with Rett syndrome.

Authors:  Tony Charman; Hilary Cass; Lucy Owen; Tony Wigram; Vicky Slonims; Lyn Weeks; Alison Wisbeach; Sheena Reilly
Journal:  Brain Dev       Date:  2002-08       Impact factor: 1.961

9.  Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents.

Authors:  P V Belichenko; A Oldfors; B Hagberg; A Dahlström
Journal:  Neuroreport       Date:  1994-07-21       Impact factor: 1.837

10.  Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.

Authors:  Sandra Luikenhuis; Emanuela Giacometti; Caroline F Beard; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

View more
  64 in total

Review 1.  Convergence of spectrums: neuronal gene network states in autism spectrum disorder.

Authors:  Josefa M Sullivan; Silvia De Rubeis; Anne Schaefer
Journal:  Curr Opin Neurobiol       Date:  2019-06-18       Impact factor: 6.627

Review 2.  Prospects for the development of epigenetic drugs for CNS conditions.

Authors:  Moshe Szyf
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

3.  Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons: IMPACT ON NEURONAL EXCITABILITY AND BREATHING.

Authors:  Weiwei Zhong; Ningren Cui; Xin Jin; Max F Oginsky; Yang Wu; Shuang Zhang; Brian Bondy; Christopher M Johnson; Chun Jiang
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

4.  Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.

Authors:  I-Ting J Wang; Arith-Ruth S Reyes; Zhaolan Zhou
Journal:  Neurobiol Dis       Date:  2013-05-06       Impact factor: 5.996

5.  Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations.

Authors:  Chiara Ciaccio; Donato Di Pierro; Diego Sbardella; Grazia Raffaella Tundo; Paolo Curatolo; Cinzia Galasso; Marta Elena Santarone; Maurizio Casasco; Paola Cozza; Alessio Cortelazzo; Marcello Rossi; Claudio De Felice; Joussef Hayek; Massimo Coletta; Stefano Marini
Journal:  Mol Cell Biochem       Date:  2017-01-07       Impact factor: 3.396

6.  The Pathophysiology of Rett Syndrome With a Focus on Breathing Dysfunctions.

Authors:  Jan-Marino Ramirez; Marlusa Karlen-Amarante; Jia-Der Ju Wang; Nicholas E Bush; Michael S Carroll; Debra E Weese-Mayer; Alyssa Huff
Journal:  Physiology (Bethesda)       Date:  2020-11-01

7.  Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology.

Authors:  Minh Vu Chuong Nguyen; Christy A Felice; Fang Du; Matthew V Covey; John K Robinson; Gail Mandel; Nurit Ballas
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.

Authors:  Valerie Matagne; Joyce Wondolowski; Matthew Frerking; Mohammad Shahidullah; Nicholas A Delamere; Ursula S Sandau; Sarojini Budden; Sergio R Ojeda
Journal:  Brain Res       Date:  2018-06-12       Impact factor: 3.252

9.  Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome.

Authors:  Valerie Matagne; Sarojini Budden; Sergio R Ojeda; Jacob Raber
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

Review 10.  Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

Authors:  S W Hulbert; Y-H Jiang
Journal:  Neuroscience       Date:  2015-12-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.